Results 151 to 160 of about 291,510 (309)

Encapsulated papillary carcinoma of the breast

open access: yesThe Breast Journal, 2021
Nikolaos S. Salemis   +1 more
openaire   +2 more sources

Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer

open access: yesBJU International, EarlyView.
Objective To describe the recurrence and progression trends of non‐muscle‐invasive bladder cancer (NMIBC) during a 14‐year period in Denmark between 2009 and 2022. Furthermore, to evaluate the risk of late recurrence with or without progression in patients who initially experience a 5‐year recurrence‐free interval (RFI).
Peter B. Hjort   +2 more
wiley   +1 more source

Ex vivo fluorescence confocal microscopy for assessment of ureteroscopic biopsy adequacy in upper tract urothelial carcinoma

open access: yesBJU International, EarlyView.
Objectives To evaluate the feasibility of ex vivo fluorescence confocal microscopy (FCM) for real‐time assessment of ureteroscopic biopsy specimen adequacy in patients with suspected upper tract urothelial carcinoma (UTUC). Patients and Methods In this prospective, single‐centre feasibility study, four ureteroscopic biopsy specimens obtained from two ...
Karim Daher   +14 more
wiley   +1 more source

Papillary carcinoma in thyroglossal duct cyst: A case report. [PDF]

open access: yesRadiol Case Rep
Rijal S, Pandey A, Karki S, Shrestha A.
europepmc   +1 more source

Small Exophytic Gastric Lesions During Sleeve Gastrectomy: A Clinical Dilemma

open access: yes
ANZ Journal of Surgery, EarlyView.
Yuchen Luo   +3 more
wiley   +1 more source

Malignant craniopharyngiomas: Institutional experience and literature review

open access: yesBrain Pathology, EarlyView.
We report the second case of malignant craniopharyngioma with BAP1 and TP53 mutations. A literature review identified 44 cases of malignant craniopharyngiomas with a median overall survival of 6 months. Eighteen (41%) occurred in patients without any history of radiation, suggesting that mechanisms other than radiation have contributed to their ...
Thomas J. Auen   +10 more
wiley   +1 more source

Discovery of a Novel γ‐Glutamylcyclotransferase Inhibitor Plumbagin by Luminescence‐Based High‐Throughput Screening

open access: yesCancer Science, EarlyView.
A cell‐based high‐throughput screening system utilizing the luminescent probe LISA‐103 was developed to monitor γ‐glutamylcyclotransferase (GGCT) activity in cancer cells. Through this assay, plumbagin was identified as a novel GGCT inhibitor that induces cell cycle arrest and suppresses cancer cell growth. ABSTRACT γ‐Glutamylcyclotransferase (GGCT) is
Keiko Taniguchi   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy